US2010003328A1PendingUtilityA1

Bone filler for cartilage tissue regeneration treatment

56
Assignee: UNIV HOKKAIDO NAT UNIV CORPPriority: Nov 29, 2006Filed: Nov 29, 2007Published: Jan 7, 2010
Est. expiryNov 29, 2026(~0.4 yrs left)· nominal 20-yr term from priority
A61L 27/52A61L 2430/02A61P 41/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

It is intended to provide a medical material which enables a new method for cartilage tissue regeneration treatment based on an entirely new concept unlike a treatment method by transplantation of autologous cartilage tissue, a cartilage alternative or undifferentiated cells. The invention provides a bone filler for cartilage tissue regeneration comprising hydrogel having an interpenetrating network structure formed by two or more crosslinked network polymers or a semi-interpenetrating network structure formed by a crosslinked network polymer and a linear polymer. By filling the bone filler of the invention in a hole or a groove provided in subchondral bone just under damaged cartilage tissue, regeneration of the cartilage tissue or both the cartilage tissue and the subchondral bone can be promoted.

Claims

exact text as granted — not AI-modified
1 : A bone-filling cartilage tissue regeneration inducer, comprising hydrogel having an interpenetrating network structure formed by two or more polymers having a crosslinked network structure or a semi-interpenetrating network structure formed by a polymer having a crosslinked network structure and a linear polymer. 
   
   
       2 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 1 , wherein a polymer having a crosslinked network structure or a linear polymer is a polymer consisting of a charged unsaturated monomer and/or an electrically neutral unsaturated monomer. 
   
   
       3 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 2 , wherein a charged unsaturated monomer is an unsaturated monomer having acidic group and/or basic group. 
   
   
       4 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 3 , wherein acidic group is carboxyl group, phosphate group, sulfonic acid group or salt consisting thereof. 
   
   
       5 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 3 , wherein an unsaturated monomer having acidic group is 2-acrylamide-2-methylpropanesulfonic acid or salt consisting thereof. 
   
   
       6 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 2 , wherein an electrically neutral unsaturated monomer is N,N-dimethyl-acrylamide. 
   
   
       7 : The bone-filling cartilage tissue regeneration inducer as set forth in  claim 1 , comprising hydrogel having an interpenetrating network structure comprising a polymer having a crosslinked network structure with 2-acrylamide-2-methylpropanesulfonic acid as a monomer and a polymer having a crosslinked network structure with N,N-dimethyl-acrylamide as a raw monomer. 
   
   
       8 : A bone-filling cartilage or cartilage tissue regeneration inducer, comprising hydrogel having an interpenetrating network structure formed by two or more polymers having a crosslinked network structure or a semi-interpenetrating network structure formed by a polymer having a crosslinked network structure and a linear polymer. 
   
   
       9 : The bone-filling cartilage or cartilage tissue regeneration inducer as set forth in  claim 8 , comprising hydrogel having an interpenetrating network structure comprising a polymer having a crosslinked network structure with 2-acrylamide-2-methylpropanesulfonic acid as a monomer and a polymer having a crosslinked network structure with N,N-dimethyl-acrylamide, acrylamide or 2-acrylamide-2-methylpropane sodium sulphate as a raw monomer.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.